{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:01:19Z","timestamp":1780758079883,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T00:00:00Z","timestamp":1540598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00394-018-1847-2","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T03:00:31Z","timestamp":1540609231000},"page":"3023-3034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Differential capability of metabolic substrates to promote hepatocellular lipid accumulation"],"prefix":"10.1007","volume":"58","author":[{"given":"Ngoc Anh","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lorkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Oliver","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2754-2435","authenticated-orcid":false,"given":"Holger","family":"Steinbrenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,27]]},"reference":[{"issue":"1","key":"1847_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000282080","volume":"28","author":"S Bellentani","year":"2010","unstructured":"Bellentani S, Scaglioni F, Marino M, Bedogni G (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis 28(1):155\u2013161. \nhttps:\/\/doi.org\/10.1159\/000282080","journal-title":"Dig Dis"},{"key":"1847_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.metabol.2017.04.011","volume":"72","author":"I Reccia","year":"2017","unstructured":"Reccia I, Kumar J, Akladios C, Virdis F, Pai M, Habib N, Spalding D (2017) Non-alcoholic fatty liver disease: a sign of systemic disease. Metabolism 72:94\u2013108. \nhttps:\/\/doi.org\/10.1016\/j.metabol.2017.04.011","journal-title":"Metabolism"},{"issue":"4","key":"1847_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","volume":"48","author":"Y Kawano","year":"2013","unstructured":"Kawano Y, Cohen DE (2013) Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 48(4):434\u2013441. \nhttps:\/\/doi.org\/10.1007\/s00535-013-0758-5","journal-title":"J Gastroenterol"},{"issue":"3","key":"1847_CR4","doi-asserted-by":"publisher","first-page":"e0173499","DOI":"10.1371\/journal.pone.0173499","volume":"12","author":"MH Le","year":"2017","unstructured":"Le MH, Devaki P, Ha NB, Jun DW, Te HS, Cheung RC, Nguyen MH (2017) Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS One 12(3):e0173499. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0173499","journal-title":"PLoS One"},{"issue":"5","key":"1847_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig 115(5):1343\u20131351. \nhttps:\/\/doi.org\/10.1172\/JCI23621","journal-title":"J Clin Investig"},{"issue":"2","key":"1847_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3945\/an.116.013730","volume":"8","author":"CC Hsu","year":"2017","unstructured":"Hsu CC, Ness E, Kowdley KV (2017) Nutritional approaches to achieve weight loss in nonalcoholic fatty liver disease. Adv Nutr 8(2):253\u2013265. \nhttps:\/\/doi.org\/10.3945\/an.116.013730","journal-title":"Adv Nutr"},{"issue":"5","key":"1847_CR7","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","volume":"61","author":"S Softic","year":"2016","unstructured":"Softic S, Cohen DE, Kahn CR (2016) Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig Dis Sci 61(5):1282\u20131293. \nhttps:\/\/doi.org\/10.1007\/s10620-016-4054-0","journal-title":"Dig Dis Sci"},{"issue":"9","key":"1847_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jnutbio.2009.05.006","volume":"20","author":"A Spruss","year":"2009","unstructured":"Spruss A, Bergheim I (2009) Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem 20(9):657\u2013662. \nhttps:\/\/doi.org\/10.1016\/j.jnutbio.2009.05.006","journal-title":"J Nutr Biochem"},{"issue":"6","key":"1847_CR9","doi-asserted-by":"publisher","first-page":"11963","DOI":"10.3390\/ijms140611963","volume":"14","author":"G Kanuri","year":"2013","unstructured":"Kanuri G, Bergheim I (2013) In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). Int J Mol Sci 14(6):11963\u201311980. \nhttps:\/\/doi.org\/10.3390\/ijms140611963","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1847_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129(1):113\u2013121","journal-title":"Gastroenterology"},{"issue":"19","key":"1847_CR11","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","volume":"18","author":"Y Takahashi","year":"2012","unstructured":"Takahashi Y, Soejima Y, Fukusato T (2012) Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol 18(19):2300\u20132308. \nhttps:\/\/doi.org\/10.3748\/wjg.v18.i19.2300","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1847_CR12","doi-asserted-by":"publisher","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","volume":"301","author":"M Charlton","year":"2011","unstructured":"Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A, Masuoko H, Gores G (2011) Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 301(5):G825\u2013G834. \nhttps:\/\/doi.org\/10.1152\/ajpgi.00145.2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"1847_CR13","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jnutbio.2015.05.011","volume":"26","author":"C Sellmann","year":"2015","unstructured":"Sellmann C, Priebs J, Landmann M, Degen C, Engstler AJ, Jin CJ, Garttner S, Spruss A, Huber O, Bergheim I (2015) Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. J Nutr Biochem 26(11):1183\u20131192. \nhttps:\/\/doi.org\/10.1016\/j.jnutbio.2015.05.011","journal-title":"J Nutr Biochem"},{"issue":"9","key":"1847_CR14","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.14670\/HH-24.1161","volume":"24","author":"GL Tipoe","year":"2009","unstructured":"Tipoe GL, Ho CT, Liong EC, Leung TM, Lau TY, Fung ML, Nanji AA (2009) Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histol Histopathol 24(9):1161\u20131169. \nhttps:\/\/doi.org\/10.14670\/HH-24.1161","journal-title":"Histol Histopathol"},{"issue":"1","key":"1847_CR15","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00192.2014","volume":"308","author":"CJ Green","year":"2015","unstructured":"Green CJ, Pramfalk C, Morten KJ, Hodson L (2015) From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. Am J Physiol Endocrinol Metab 308(1):E1\u2013E20. \nhttps:\/\/doi.org\/10.1152\/ajpendo.00192.2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1847_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-230X-12-20","volume":"12","author":"NC Chavez-Tapia","year":"2012","unstructured":"Chavez-Tapia NC, Rosso N, Tiribelli C (2012) Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. BMC Gastroenterol 12:20. \nhttps:\/\/doi.org\/10.1186\/1471-230X-12-20","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"1847_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","volume":"165","author":"MJ Gomez-Lechon","year":"2007","unstructured":"Gomez-Lechon MJ, Donato MT, Martinez-Romero A, Jimenez N, Castell JV, O\u2019Connor JE (2007) A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact 165(2):106\u2013116. \nhttps:\/\/doi.org\/10.1016\/j.cbi.2006.11.004","journal-title":"Chem Biol Interact"},{"issue":"11","key":"1847_CR18","doi-asserted-by":"publisher","first-page":"e26583","DOI":"10.1371\/journal.pone.0026583","volume":"6","author":"KM Hirahatake","year":"2011","unstructured":"Hirahatake KM, Meissen JK, Fiehn O, Adams SH (2011) Comparative effects of fructose and glucose on lipogenic gene expression and intermediary metabolism in HepG2 liver cells. PLoS One 6(11):e26583. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0026583","journal-title":"PLoS One"},{"issue":"5","key":"1847_CR19","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","volume":"24","author":"M Ricchi","year":"2009","unstructured":"Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A, Fantoni LI, Marra F, Bertolotti M, Banni S, Lonardo A, Carulli N, Loria P (2009) Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol 24(5):830\u2013840. \nhttps:\/\/doi.org\/10.1111\/j.1440-1746.2008.05733.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1847_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.abb.2014.12.009","volume":"566","author":"M Ishii","year":"2015","unstructured":"Ishii M, Maeda A, Tani S, Akagawa M (2015) Palmitate induces insulin resistance in human HepG2 hepatocytes by enhancing ubiquitination and proteasomal degradation of key insulin signaling molecules. Arch Biochem Biophys 566:26\u201335. \nhttps:\/\/doi.org\/10.1016\/j.abb.2014.12.009","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"1847_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1515\/hsz-2014-0102","volume":"395","author":"AM Rajalin","year":"2014","unstructured":"Rajalin AM, Micoogullari M, Sies H, Steinbrenner H (2014) Upregulation of the thioredoxin-dependent redox system during differentiation of 3T3-L1 cells to adipocytes. Biol Chem 395(6):667\u2013677. \nhttps:\/\/doi.org\/10.1515\/hsz-2014-0102","journal-title":"Biol Chem"},{"key":"1847_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.redox.2016.12.003","volume":"11","author":"N Urban","year":"2017","unstructured":"Urban N, Tsitsipatis D, Hausig F, Kreuzer K, Erler K, Stein V, Ristow M, Steinbrenner H, Klotz LO (2017) Non-linear impact of glutathione depletion on C. elegans life span and stress resistance. Redox Biol 11:502\u2013515. \nhttps:\/\/doi.org\/10.1016\/j.redox.2016.12.003","journal-title":"Redox Biol"},{"issue":"6","key":"1847_CR23","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.22526","volume":"48","author":"B Speckmann","year":"2008","unstructured":"Speckmann B, Walter PL, Alili L, Reinehr R, Sies H, Klotz LO, Steinbrenner H (2008) Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors. Hepatology 48(6):1998\u20132006. \nhttps:\/\/doi.org\/10.1002\/hep.22526","journal-title":"Hepatology"},{"issue":"8","key":"1847_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbalip.2018.05.002","volume":"1863","author":"L Schmolz","year":"2018","unstructured":"Schmolz L, Schubert M, Kirschner J, Kluge S, Galli F, Birringer M, Wallert M, Lorkowski S (2018) Long-chain metabolites of vitamin E: Interference with lipotoxicity via lipid droplet associated protein PLIN2. Biochim Biophys Acta Mol Cell Biol Lipids 1863(8):919\u2013927. \nhttps:\/\/doi.org\/10.1016\/j.bbalip.2018.05.002","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"50","key":"1847_CR25","doi-asserted-by":"publisher","first-page":"29692","DOI":"10.1074\/jbc.E115.000002","volume":"290","author":"AJ Fosang","year":"2015","unstructured":"Fosang AJ, Colbran RJ (2015) Transparency is the key to quality. J Biol Chem 290(50):29692\u201329694. \nhttps:\/\/doi.org\/10.1074\/jbc.E115.000002","journal-title":"J Biol Chem"},{"issue":"6865","key":"1847_CR26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813\u2013820. \nhttps:\/\/doi.org\/10.1038\/414813a","journal-title":"Nature"},{"issue":"3","key":"1847_CR27","doi-asserted-by":"publisher","first-page":"E499","DOI":"10.1152\/ajpendo.00507.2009","volume":"298","author":"AT Sage","year":"2010","unstructured":"Sage AT, Walter LA, Shi Y, Khan MI, Kaneto H, Capretta A, Werstuck GH (2010) Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells. Am J Physiol Endocrinol Metab 298(3):E499\u2013E511. \nhttps:\/\/doi.org\/10.1152\/ajpendo.00507.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"1847_CR28","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/hep.22268","volume":"47","author":"BK Straub","year":"2008","unstructured":"Straub BK, Stoeffel P, Heid H, Zimbelmann R, Schirmacher P (2008) Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis. Hepatology 47(6):1936\u20131946. \nhttps:\/\/doi.org\/10.1002\/hep.22268","journal-title":"Hepatology"},{"issue":"31","key":"1847_CR29","doi-asserted-by":"publisher","first-page":"22678","DOI":"10.1074\/jbc.M704213200","volume":"282","author":"CS Choi","year":"2007","unstructured":"Choi CS, Savage DB, Kulkarni A, Yu XX, Liu ZX, Morino K, Kim S, Distefano A, Samuel VT, Neschen S, Zhang D, Wang A, Zhang XM, Kahn M, Cline GW, Pandey SK, Geisler JG, Bhanot S, Monia BP, Shulman GI (2007) Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J Biol Chem 282(31):22678\u201322688. \nhttps:\/\/doi.org\/10.1074\/jbc.M704213200","journal-title":"J Biol Chem"},{"issue":"2","key":"1847_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/hep.20783","volume":"42","author":"XX Yu","year":"2005","unstructured":"Yu XX, Murray SF, Pandey SK, Booten SL, Bao D, Song XZ, Kelly S, Chen S, McKay R, Monia BP, Bhanot S (2005) Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 42(2):362\u2013371. \nhttps:\/\/doi.org\/10.1002\/hep.20783","journal-title":"Hepatology"},{"issue":"15","key":"1847_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1089\/scd.2015.0383","volume":"25","author":"N Graffmann","year":"2016","unstructured":"Graffmann N, Ring S, Kawala MA, Wruck W, Ncube A, Trompeter HI, Adjaye J (2016) Modeling nonalcoholic fatty liver disease with human pluripotent stem cell-derived immature hepatocyte-like cells reveals activation of PLIN2 and confirms regulatory functions of peroxisome proliferator-activated receptor alpha. Stem Cells Dev 25(15):1119\u20131133. \nhttps:\/\/doi.org\/10.1089\/scd.2015.0383","journal-title":"Stem Cells Dev"},{"issue":"2","key":"1847_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0092-8674(74)90116-0","volume":"3","author":"H Green","year":"1974","unstructured":"Green H, Meuth M (1974) An established pre-adipose cell line and its differentiation in culture. Cell 3(2):127\u2013133","journal-title":"Cell"},{"issue":"3","key":"1847_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146(3):726\u2013735. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2013.11.049","journal-title":"Gastroenterology"},{"issue":"2","key":"1847_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.foodchem.2012.09.012","volume":"136","author":"MT Do","year":"2013","unstructured":"Do MT, Kim HG, Choi JH, Khanal T, Park BH, Tran TP, Hwang YP, Na M, Jeong HG (2013) Phillyrin attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1\/AMP-activated protein kinase-dependent signalling. Food Chem 136(2):415\u2013425. \nhttps:\/\/doi.org\/10.1016\/j.foodchem.2012.09.012","journal-title":"Food Chem"},{"issue":"9","key":"1847_CR35","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.bbadis.2014.07.002","volume":"1842","author":"H Li","year":"2014","unstructured":"Li H, Min Q, Ouyang C, Lee J, He C, Zou MH, Xie Z (2014) AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response. Biochim Biophys Acta 1842(9):1844\u20131854. \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2014.07.002","journal-title":"Biochim Biophys Acta"},{"key":"1847_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.lfs.2017.02.001","volume":"173","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Takemori H, Wang C, Fu J, Xu M, Xiong L, Li N, Wen X (2017) Role of salt inducible kinase 1 in high glucose-induced lipid accumulation in HepG2 cells and metformin intervention. Life Sci 173:107\u2013115. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2017.02.001","journal-title":"Life Sci"},{"issue":"8","key":"1847_CR37","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1073\/pnas.0914798107","volume":"107","author":"S Li","year":"2010","unstructured":"Li S, Brown MS, Goldstein JL (2010) Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci USA 107(8):3441\u20133446. \nhttps:\/\/doi.org\/10.1073\/pnas.0914798107","journal-title":"Proc Natl Acad Sci USA"},{"key":"1847_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jnutbio.2017.06.003","volume":"47","author":"D Bartolini","year":"2017","unstructured":"Bartolini D, Torquato P, Barola C, Russo A, Rychlicki C, Giusepponi D, Bellezza G, Sidoni A, Galarini R, Svegliati-Baroni G, Galli F (2017) Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of alpha-tocopherol (vitamin E). J Nutr Biochem 47:120\u2013131. \nhttps:\/\/doi.org\/10.1016\/j.jnutbio.2017.06.003","journal-title":"J Nutr Biochem"},{"issue":"4","key":"1847_CR39","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mnfr.201500635","volume":"60","author":"L Zhao","year":"2016","unstructured":"Zhao L, Guo X, Wang O, Zhang H, Wang Y, Zhou F, Liu J, Ji B (2016) Fructose and glucose combined with free fatty acids induce metabolic disorders in HepG2 cell: a new model to study the impacts of high-fructose\/sucrose and high-fat diets in vitro. Mol Nutr Food Res 60(4):909\u2013921. \nhttps:\/\/doi.org\/10.1002\/mnfr.201500635","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"1847_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11306-014-0729-8","volume":"11","author":"JK Meissen","year":"2015","unstructured":"Meissen JK, Hirahatake KM, Adams SH, Fiehn O (2015) Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glucose exposures. Metabolomics 11(3):707\u2013721. \nhttps:\/\/doi.org\/10.1007\/s11306-014-0729-8","journal-title":"Metabolomics"},{"issue":"1","key":"1847_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.atherosclerosis.2011.07.108","volume":"219","author":"DR Beriault","year":"2011","unstructured":"Beriault DR, Sharma S, Shi Y, Khan MI, Werstuck GH (2011) Glucosamine-supplementation promotes endoplasmic reticulum stress, hepatic steatosis and accelerated atherogenesis in apoE\u2212\/\u2212 mice. Atherosclerosis 219(1):134\u2013140. \nhttps:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.07.108","journal-title":"Atherosclerosis"},{"key":"1847_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.biochi.2013.08.026","volume":"96","author":"C Sztalryd","year":"2014","unstructured":"Sztalryd C, Kimmel AR (2014) Perilipins: lipid droplet coat proteins adapted for tissue-specific energy storage and utilization, and lipid cytoprotection. Biochimie 96:96\u2013101. \nhttps:\/\/doi.org\/10.1016\/j.biochi.2013.08.026","journal-title":"Biochimie"},{"issue":"3","key":"1847_CR43","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jhep.2013.11.007","volume":"60","author":"LM Pawella","year":"2014","unstructured":"Pawella LM, Hashani M, Eiteneuer E, Renner M, Bartenschlager R, Schirmacher P, Straub BK (2014) Perilipin discerns chronic from acute hepatocellular steatosis. J Hepatol 60(3):633\u2013642. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2013.11.007","journal-title":"J Hepatol"},{"issue":"1","key":"1847_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1194\/jlr.M500170-JLR200","volume":"47","author":"Y Masuda","year":"2006","unstructured":"Masuda Y, Itabe H, Odaki M, Hama K, Fujimoto Y, Mori M, Sasabe N, Aoki J, Arai H, Takano T (2006) ADRP\/adipophilin is degraded through the proteasome-dependent pathway during regression of lipid-storing cells. J Lipid Res 47(1):87\u201398. \nhttps:\/\/doi.org\/10.1194\/jlr.M500170-JLR200","journal-title":"J Lipid Res"},{"issue":"6","key":"1847_CR45","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/ncb3166","volume":"17","author":"S Kaushik","year":"2015","unstructured":"Kaushik S, Cuervo AM (2015) Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis. Nat Cell Biol 17(6):759\u2013770. \nhttps:\/\/doi.org\/10.1038\/ncb3166","journal-title":"Nat Cell Biol"},{"issue":"42","key":"1847_CR46","doi-asserted-by":"publisher","first-page":"38870","DOI":"10.1074\/jbc.M106219200","volume":"276","author":"S Cases","year":"2001","unstructured":"Cases S, Stone SJ, Zhou P, Yen E, Tow B, Lardizabal KD, Voelker T, Farese RV Jr (2001) Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 276(42):38870\u201338876. \nhttps:\/\/doi.org\/10.1074\/jbc.M106219200","journal-title":"J Biol Chem"},{"issue":"3","key":"1847_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0006-291X(02)02466-X","volume":"298","author":"RL Meegalla","year":"2002","unstructured":"Meegalla RL, Billheimer JT, Cheng D (2002) Concerted elevation of acyl-coenzyme A: diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin. Biochem Biophys Res Commun 298(3):317\u2013323","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1847_CR48","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10534-016-9960-2","volume":"29","author":"S Wang","year":"2016","unstructured":"Wang S, Wang J, Zhang X, Hu L, Fang Z, Huang Z, Shi P (2016) Trivalent chromium alleviates oleic acid induced steatosis in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis. Biometals 29(5):881\u2013892. \nhttps:\/\/doi.org\/10.1007\/s10534-016-9960-2","journal-title":"Biometals"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-018-1847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-018-1847-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-018-1847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T03:11:48Z","timestamp":1573269108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-018-1847-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,27]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1847"],"URL":"https:\/\/doi.org\/10.1007\/s00394-018-1847-2","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,27]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}